A Delaware judge on Wednesday agreed with Roivant subsidiary Arbutus and Genevant’s interpretation of specific patent claims regarding the lipid nanoparticle delivery system used by Moderna’s COVID-19 vaccine.
Tag Archive for: Arbutus
A U.S. appeals court handed Moderna Inc. a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp. patent related to the companies’ legal fight over Moderna’s blockbuster COVID-19 vaccines.
Arbutus Biopharma on Tuesday sued U.S. drugmaker Pfizer Inc. and its German partner BioNTech SE in a New Jersey district court, claiming their mRNA COVID-19 vaccines infringe five of Arbutus’ patents.
Moderna is dropping an IL-2 program in autoimmune disorders after AstraZeneca returned the rights, the mRNA leader announced Thursday in its third quarter filing.
